SK Biopharmaceuticals Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Dong Hoon Lee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.004% |
| Management average tenure | no data |
| Board average tenure | 2.7yrs |
CEO
Dong Hoon Lee (55 yo)
2.3yrs
Tenure
Mr. Dong Hoon Lee serves as Chief Executive Officer of SK Biopharmaceuticals Co., Ltd. since 2022 and also served as its Chairman of the Board since February 26, 2020. He is President of SK Biopharmaceutic...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 4.3yrs | no data | 0.0038% ₩ 266.3m | |
| CFO & Executive Director | less than a year | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | 1.2yrs | no data | no data | |
| Independent Chairman of the Board | 4.8yrs | no data | no data | |
| Chairman of the Scientific Advisory Board | less than a year | no data | no data | |
| Independent Outside Director | 4.8yrs | no data | no data |
2.7yrs
Average Tenure
Experienced Board: A326030's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.